Sabra Healthcare REIT (NASDAQ:SBRA) Posts Earnings Results, Misses Estimates By $0.27 EPS

Sabra Healthcare REIT (NASDAQ:SBRA) issued its quarterly earnings data on Monday. The real estate investment trust reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.17 by ($0.27), FiscalAI reports. The company had revenue of $230.11 million during the quarter, compared to analysts’ expectations of $219.39 million. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The firm’s revenue was up 24.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.38 earnings per share.

Sabra Healthcare REIT Price Performance

Sabra Healthcare REIT stock opened at $20.61 on Tuesday. Sabra Healthcare REIT has a 1 year low of $17.17 and a 1 year high of $22.77. The firm has a 50 day moving average price of $19.77 and a 200 day moving average price of $19.93. The company has a market cap of $5.20 billion, a price-to-earnings ratio of 32.71, a PEG ratio of 1.64 and a beta of 0.64. The company has a debt-to-equity ratio of 0.96, a quick ratio of 4.72 and a current ratio of 4.72.

Sabra Healthcare REIT Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Friday, August 14th will be given a $0.30 dividend. The ex-dividend date of this dividend is Friday, August 14th. This represents a $1.20 annualized dividend and a dividend yield of 5.8%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 190.48%.

Analyst Upgrades and Downgrades

SBRA has been the subject of several analyst reports. Weiss Ratings downgraded shares of Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a research note on Thursday, June 4th. Scotiabank cut their price objective on shares of Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating for the company in a research report on Thursday, June 18th. Raymond James Financial started coverage on shares of Sabra Healthcare REIT in a research note on Wednesday, June 17th. They set an “underperform” rating on the stock. Citigroup restated a “market outperform” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, July 22nd. Finally, UBS Group set a $25.00 price objective on Sabra Healthcare REIT in a research report on Wednesday, July 22nd. Eight research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $22.25.

Hedge Funds Weigh In On Sabra Healthcare REIT

A number of large investors have recently bought and sold shares of the stock. Focus Partners Wealth raised its position in shares of Sabra Healthcare REIT by 11.4% in the 1st quarter. Focus Partners Wealth now owns 23,146 shares of the real estate investment trust’s stock worth $404,000 after buying an additional 2,375 shares during the period. EverSource Wealth Advisors LLC grew its position in Sabra Healthcare REIT by 150.7% during the second quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock valued at $47,000 after acquiring an additional 1,536 shares during the period. First Trust Advisors LP increased its stake in Sabra Healthcare REIT by 27.2% during the second quarter. First Trust Advisors LP now owns 368,383 shares of the real estate investment trust’s stock worth $6,793,000 after acquiring an additional 78,709 shares during the last quarter. Cerity Partners LLC increased its stake in Sabra Healthcare REIT by 73.0% during the second quarter. Cerity Partners LLC now owns 18,686 shares of the real estate investment trust’s stock worth $345,000 after acquiring an additional 7,885 shares during the last quarter. Finally, Daiwa Securities Group Inc. raised its holdings in shares of Sabra Healthcare REIT by 3.1% in the 2nd quarter. Daiwa Securities Group Inc. now owns 83,889 shares of the real estate investment trust’s stock worth $1,547,000 after purchasing an additional 2,557 shares during the period. Hedge funds and other institutional investors own 99.40% of the company’s stock.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.